Zymeworks Inc.
ZYME
$27.50
-$0.62-2.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -90.58% | -91.12% | -91.90% | 72.59% | 153.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -90.58% | -91.12% | -91.90% | 72.59% | 153.21% |
| Cost of Revenue | -20.36% | -3.58% | -15.72% | -2.13% | 13.54% |
| Gross Profit | -260.01% | -271.45% | -376.13% | 60.87% | 228.64% |
| SG&A Expenses | 29.32% | -11.28% | -4.65% | 2.12% | -4.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.32% | -6.06% | -12.36% | -0.96% | 7.34% |
| Operating Income | -6,158.16% | -83.96% | -98.73% | 35.36% | 97.48% |
| Income Before Tax | -2,225.39% | -109.36% | -133.15% | 38.34% | 105.66% |
| Income Tax Expenses | -46.77% | -541.73% | -104.72% | 491.15% | -373.53% |
| Earnings from Continuing Operations | -2,042.99% | -95.10% | -75.31% | 34.33% | 106.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2,042.99% | -95.10% | -75.31% | 34.33% | 106.15% |
| EBIT | -6,158.16% | -83.96% | -98.73% | 35.36% | 97.48% |
| EBITDA | -2,359.05% | -99.78% | -124.11% | 36.14% | 107.31% |
| EPS Basic | -2,102.60% | -96.41% | -73.76% | 34.02% | 106.24% |
| Normalized Basic EPS | -2,290.96% | -110.76% | -131.09% | 38.03% | 110.06% |
| EPS Diluted | -2,173.58% | -95.19% | -73.76% | 33.56% | 106.05% |
| Normalized Diluted EPS | -2,354.65% | -110.93% | -131.25% | 38.01% | 109.77% |
| Average Basic Shares Outstanding | -3.11% | -0.67% | 0.91% | -0.47% | -1.38% |
| Average Diluted Shares Outstanding | -5.67% | -0.71% | 0.83% | -0.50% | 1.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |